Stocks Special Reports LICs Credit Technical Analysis Funds ETFs Tools SMSFs
Learn
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features Technical Analysis SMSFs Learn
About

News

Oh, inverted world

Martin Conlon  |  28 Sep 2016Text size  Decrease  Increase  |  

Page 1 of 1

Schroders' head of Australian equities Martin Conlon gives an update on the effect of government policy on markets and unintended distortions for some industries, in particular business duration.

 

"Oh, Inverted World" may be familiar to fans of indie music as the title of The Shins debut album. However, it is also a fair summation of our views on the world and investment markets.

Fed officials gather at Jackson Hole to determine what's best for the US economy, the ECB is buying every corporate bond they can find at any price and the Australian parliament is convinced they can be the engine of economic growth and stave off any downturn.

None contemplate they may be the source of low growth rather than the panacea for it. As focus heightens on the limits and unintended consequences of unconventional monetary policy, economists now believe the solution lies in more aggressive fiscal policy.

History shows governments not to be the most effective spenders in the economy, so forgive us if we retain some cynicism on this course of action.

Insurance companies are front and centre when it comes to the impact of interest rate distortion, as they are obligated to invest in low-risk assets to match insurance liabilities. The QBE Insurance (ASX: QBE) result typified the global environment.

Insurance companies used to underwrite on the basis that the time lag between receiving premiums and paying claims would allow them to earn an investment return.

As purveyors of financial capital, insurers now find the world awash with excess capital, resulting in ever greater risk for ever lower returns.

Combined with virtually zero investment return, profitability is under intense pressure, even in a benign catastrophe environment.

As always, the government-directed quagmire which is the healthcare industry, led the way when it comes to economic distortions.

It is clear the already high returns being earned by operators such as Ramsay (ASX: RHC) are being extrapolated into the future given multiples of 20 times EBIT (earnings before interest and tax) and more than 30 times earnings.

We remain extremely wary of extrapolating ever higher returns for a business which already exhibits super profitability, earns virtually none of its profits in free markets and benefits from payers and governments convinced that constraining supply is the best way to control outlays, not to mention the aggressive use of financial leverage.

We won't even start on drug and medical device pricing, which again, results in outsized profitability and returns emanating from socialised pricing.

When consumers believe a hepatitis C drug which costs $20,000 a dose actually costs $6, it shouldn't come as an enormous surprise that demand is a little stronger than at the true cost.

While we could cite other examples of ongoing and increasing distortion, it is perhaps worth touching on another glaring anomaly we see in market pricing; one prevalent far more in the mid- and small-cap end of the market.

It is that of business duration.

Discounted cash flow remains one of the weapons of mass destruction most readily available to financial analysts, due to the ease with which it facilitates a generic assumption that every business exists in perpetuity.

Additionally, where recent experience has been favourable, this invariably provides the anchor for assuming this experience into perpetuity. A cursory examination of the facts would suggest the probability of businesses existing in perpetuity is neither high nor uniform.

Perversely, as discount rates move ever lower, the importance of this duration continues to elevate.

We often hear claims that scarcity of growth in the current environment should elevate the prices investors are prepared to pay for it.

We feel the hiccups for stocks such as Blackmores (ASX: BKL), APN Outdoor (ASX: APO) and Surfstitch (ASX: SRF) should be reminders of the importance of business durability to value in an environment in which infatuation with short-term growth has become manic.

They may be unfashionable, but long-dated mine lives of businesses like Rio Tinto (ASX: RIO) and BHP Billiton (ASX: BHP), or global pallet pooling businesses like Brambles (ASX: BXB) with very high entry barriers might not have the short-term growth of these "capital-light" peers, but evidence and analysis would suggest they are far more likely to be long duration assets than many of the "capital-light" peers in technology and consumer discretionary areas which are currently winning the popularity contest.

Outlook

The aforementioned distortions which remain as prevalent as ever are amplifying the headwinds for some businesses and the tailwinds for others.

This is likely to both enhance volatility and severely impact the usefulness of traditional valuation measures such as P/E ratios, not to mention the discounted cash flow models used by those experts in the art of extrapolation.

For those willing to look past current distortions and embrace duration rather than immediate earnings satisfaction, we believe opportunities are still relatively abundant despite market levels which remain artificially buoyant.

More from Morningstar

• Why China's debt-fuelled economic expansion can't keep happening

• India, China hold pockets of investment opportunity

 

Martin Conlon is head of Australian equities at Schroders. This is a financial news article to be used for non-commercial purposes and is not intended to provide financial advice of any kind.

© 2016 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written content of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO"). The article is current as at date of publication.